Epithelial ovarian cancer: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{| class="wikitable"
{| class="wikitable"
|+
|+
!Malignancies associated with BRCA mutations (Hereditary breast and ovarian cancer syndrome)<ref name="pmid26557407">{{cite journal |vauthors=Famorca-Tran J, Roux G |title=The Consequences of a BRCA Mutation in Women |journal=J Adv Pract Oncol |volume=6 |issue=3 |pages=194–210 |date=2015 |pmid=26557407 |pmc=4625626 |doi= |url=}}</ref>
!style="background:#4479BA; color: #FFFFFF;" align="center" + |Malignancies associated with BRCA mutations (Hereditary breast and ovarian cancer syndrome)<ref name="pmid26557407">{{cite journal |vauthors=Famorca-Tran J, Roux G |title=The Consequences of a BRCA Mutation in Women |journal=J Adv Pract Oncol |volume=6 |issue=3 |pages=194–210 |date=2015 |pmid=26557407 |pmc=4625626 |doi= |url=}}</ref>
|-
|-
|
|

Revision as of 18:26, 25 February 2019


Malignancies associated with BRCA mutations (Hereditary breast and ovarian cancer syndrome)[1]
  • Breast cancer (male and female)
  • Ovarian cancer
  • Fallopian tube carcinoma
  • Primary papillary carcinoma of the peritoneum
  • Prostate cancer
  • Uterine body cancer
  • Cervical cancer
  • Pancreatic cancer
  • Gall bladder cancer
  • Bile duct cancer
  • Stomach cancer
  • Melanoma

Template:Epithelial ovarian cancer Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2]

  1. Famorca-Tran J, Roux G (2015). "The Consequences of a BRCA Mutation in Women". J Adv Pract Oncol. 6 (3): 194–210. PMC 4625626. PMID 26557407.